Explores the controversy over the price of AIDS drugs in poor countries. This issue has received much publicity due to two events: 1) a court in South Africa, which seeks to force pharmaceutical companies to license their patents, and 2) a statement of Indian pharmaceutical company, Cipla, which would copy the AIDS American companies' drugs and sell them at cost Africa. consists of excerpts from 10 articles and highlights the strong feelings on both sides of the issue. encourages students to think about the short-and long-term consequences of different approaches, the role of states and international organizations, and the pressure faced by the leaders of the pharmaceutical companies. "Hide
by Robert Kennedy Source: Harvard Business School 14 pages. Publication Date: August 13, 2001. Prod. #: 702010-PDF-ENG
Related Case Solutions & Analyses:
International Bankruptcy and the Spirit of Comity: New U.S. Law Encourages Cooperation Among Nations
Nike Inc. – Heading Toward 2012
The Challenge Facing the U.S. Healthcare Delivery System
DVD War
Aventis S(A): Planning for a Merger
A Note on Cost Reduction in Financially Troubled Organizations
Amgen Inc.’s Epogen–Commercializing the First Biotech Blockbuster Drug
Analysis of Income Statement
Amazonite Enterprises
WILDCAT CAPITAL INVESTOR
